StonvexLoading…
StonvexCore line items from LMNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-06-09 | Q1 2026 2026-01-31 | Annual 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|---|
Revenue | $21.37M | $16.76M | $153.69M | $112.38M | $66.43M |
Operating Income | Not available | $-10.55M | $-20.41M | $-9.32M | $-8.69M |
Net Income | Not available | $-9.43M | $-15.98M | $-7.29M | $-6.43M |
EPS (Diluted) | $-0.21 | $-0.53 | $-0.93 | $-0.43 | $-0.38 |
Total Assets | Not available | $307.53M | $311.14M | $299.91M | $296.63M |
Total Liabilities | Not available | $126.88M | $120.30M | $108.81M | $103.17M |
Cash & Equivalents | Not available | $1.27M | $1.51M | $2.11M | $2.08M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 18.11M | 18.04M | 18.05M | 18.07M |